Back
Nathan's Famous Vs. Alnylam Pharmaceuticals Industry Stock Comparison
Buy
52
NATH
Nathan's Famous
Last Price:
$94.75
Seasonality Move:
1.2%
Sell
43
ALNY
Alnylam Pharmaceuticals
Last Price:
$268.29
Seasonality Move:
7.6%
Buy
52
Nathan's Famous (NATH)
is a Buy
Is Nathan's Famous a Buy, Sell or Hold?
-
The current Nathan's Famous [NATH] share price is $94.92. The Score for NATH is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
-
NATH is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
43
Alnylam Pharmaceuticals (ALNY)
is a Sell
Is Alnylam Pharmaceuticals a Buy, Sell or Hold?
-
The current Alnylam Pharmaceuticals [ALNY] share price is $271.02. The Score for ALNY is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
-
ALNY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
NATH Stock Price Chart
What is Nathan's Famous's stock price today?
-
The Nathan's Famous share price today is $94.92Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NATH is experiencing selling pressure, which indicates risk of future bearish movement.
ALNY Stock Price Chart
What is Alnylam Pharmaceuticals's stock price today?
-
The Alnylam Pharmaceuticals share price today is $271.02The current trend is moderately bullish and ALNY is experiencing slight buying pressure.
NATH Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.42 | Buy |
| Relative Strength Index (14 RSI): | 52.13 | Buy |
| Chaikin Money Flow: | -6860 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (93.36 - 100.56) | Sell |
| Bollinger Bands (100): | (79.94 - 94.52) | Buy |
ALNY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 5.53 | Buy |
| Relative Strength Index (14 RSI): | 57.28 | Buy |
| Chaikin Money Flow: | 106003 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (238.42 - 267) | Buy |
| Bollinger Bands (100): | (240.58 - 270.64) | Buy |
NATH Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 94.41 | Buy |
| 20-day SMA: | 95.81 | Sell |
| 50-day SMA: | 90.33 | Buy |
| 200-day SMA: | 81.25 | Buy |
| 8-day EMA: | 94.39 | Buy |
| 20-day EMA: | 94.59 | Buy |
| 50-day EMA: | 91.76 | Buy |
| 200-day EMA: | 83.1 | Buy |
ALNY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 268.31 | Buy |
| 20-day SMA: | 253.84 | Buy |
| 50-day SMA: | 259.68 | Buy |
| 200-day SMA: | 253.36 | Buy |
| 8-day EMA: | 268.69 | Buy |
| 20-day EMA: | 260.57 | Buy |
| 50-day EMA: | 257.45 | Buy |
| 200-day EMA: | 244.33 | Buy |
Nathan's Famous Earnings Growth & NATH Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.91 per share, an increase next quarter of $0.05 per share, an increase this year of $1.08 per share, and an increase next year of $2.75 per share.
Nathan's Famous Technical Analysis
| Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | ||||||||||
| 14 | 17 | 18 | 19 | 20 | 21 | 24 | 25 | 26 | 27 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Alnylam Pharmaceuticals Technical Analysis
| Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | ||||||||||
| 14 | 17 | 18 | 19 | 20 | 21 | 24 | 25 | 26 | 27 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||